Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])

NCT03139513

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centre Hospitalier d'Albi Albi, France
  • Hopital Prive D Antony; Dermatologie Antony, France
  • Chic Cote Basque Bayonne; Medecine II Bayonne, France
  • CHU Besançon - Hôpital Jean Minjoz Besançon, France
View all 33 locations
View Trial Details
Completed

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

NCT01004887

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho, United States
View all 110 locations
View Trial Details
Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

NCT01262235

Conditions
ACC, Adenocarcinoma, Adrenal Cortex Diseases, +26 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Completed

Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])

NCT01119560

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 153 locations
View Trial Details

Related conditions